戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t and human intestinal epithelial cells into insulin-secreting cells.
2  of cyclic adenosine monophosphate (cAMP) in insulin-secreting cells.
3 ing intestinal cells into glucose-responsive insulin-secreting cells.
4 re competent to generate glucose-responsive, insulin-secreting cells.
5 echanism to a specific perinuclear region of insulin-secreting cells.
6 ) channels in human beta cells and rat INS-1 insulin-secreting cells.
7 fferentiate the acinar-like AR42J cells into insulin-secreting cells.
8  Ca(2+)-activated K(+) (SK) channel genes in insulin-secreting cells.
9     We tested the methods with glucagon- and insulin-secreting cells.
10 endent K+ current (IK(Ca)) in mouse betaTC-3 insulin-secreting cells.
11 y intracellular beta-NAD+, present in CRI-G1 insulin-secreting cells.
12 hat leptin (0.3-10 nm) hyperpolarizes CRI-G1 insulin-secreting cells.
13 olbutamide-sensitive KATP channels in CRI-G1 insulin-secreting cells.
14  and stimulate insulin secretion from CRI-G1 insulin-secreting cells.
15 ed propensity for conversion into functional insulin-secreting cells.
16                                           In insulin secreting cells a surprisingly large fraction of
17 entiation of human embryonic stem cells into insulin-secreting cells, achieving an elusive goal for r
18 -cells, and overexpression of CTSH protected insulin-secreting cells against cytokine-induced apoptos
19 d IK1 (SK4) are expressed in islet cells and insulin-secreting cells and are able to influence glucos
20 lation, protein expression, and stability in insulin-secreting cells and isolated rodent islets of La
21 s establish novel actions for NA and G(z) in insulin-secreting cells and possibly other cell types.
22 ties but also notable differences between S7 insulin-secreting cells and primary human beta cells.
23 s possible to convert adult fibroblasts into insulin-secreting cells, avoiding both a stable pluripot
24 ntration of free ADP in betaHC9 hyperplastic insulin-secreting cells based on the cell diameter and o
25 pithelial cells could be differentiated into insulin-secreting cells by exposing them to GLP-1.
26                                           In insulin-secreting cells, catechol estrogens produced rap
27 ively low endogenous Spl expression level in insulin-secreting cells contributes to their extraordina
28 Transplantation of pancreatic progenitors or insulin-secreting cells derived from human embryonic ste
29 ating the mitochondrial apoptotic pathway in insulin-secreting cells during ER stress.
30          Overexpression of SOX4 in the human insulin-secreting cell EndoC-betaH2 interfered with gran
31                                           In insulin-secreting cells, expression of NADPH oxidase (NO
32 regulated methylation-demethylation cycle in insulin-secreting cells, findings that may imply an impo
33 provides hope for self-renewal of functional insulin-secreting cells following beta-cell failure, a h
34 ategies to provide a replenishable supply of insulin-secreting cells for the treatment of diabetes me
35 ntify a ROCKII inhibitor H1152 as increasing insulin secreting cells from hPSCs and improving beta-ce
36                            We show here that insulin-secreting cells from a homogeneous group of five
37 e miR-29 binding site on Mcl1 mRNA protected insulin-secreting cells from apoptosis triggered by miR-
38 en possible to generate abundant and durable insulin-secreting cells from human gut tissues to evalua
39           We show that silencing of DIMT1 in insulin-secreting cells impacted mitochondrial function,
40 ve beta-like cells similar to the endogenous insulin-secreting cells in mice.
41 ypeptide, which is implicated in the loss of insulin-secreting cells in type II diabetics.
42 ore active than the upstream promoter (A) in insulin-secreting cells (INS-1) and HeLa cells.
43 brane permeability of 8-pCPT-2'-O-Me-cAMP in insulin-secreting cells is so low as to limit its biolog
44 ion ([Ca2+]i) in apoptosis in MIN6 cells, an insulin secreting cell line, and in mouse islets.
45 ne prior study of human beta-cells and a rat insulin-secreting cell line (INS-1 cells) in which it wa
46 or genetic ablation of beta-arrestin 2 in an insulin-secreting cell line and mouse pancreatic islets,
47 e electrofusion-derived, glucose-responsive, insulin-secreting cell line BRIN-BD11 using patch-clamp
48 cells (GLUTag) and in vivo in mice using the insulin-secreting cell line INS-1 832/13 as reference.
49 ion efficiency as wild type channels, in the insulin-secreting cell line INS-1.
50 ic reticulum Ca2+ stores was assessed in the insulin-secreting cell line INS-1.
51                                    Using the insulin-secreting cell line INS-1E, we found that glucos
52  K(ATP) channels in BRIN-BD11 cells, a novel insulin-secreting cell line produced by electrofusion te
53               NES2Y is a proliferating human insulin-secreting cell line that we have derived from a
54 COX-1 and COX-2 mRNAs in MIN6 cells, a mouse insulin-secreting cell line, and in primary mouse and hu
55 (beta-NAD+)-activated ion channel in the rat insulin-secreting cell line, CRI-G1.
56  either bovine chromaffin cells or the INS-1 insulin-secreting cell line.
57 l alpha1-subunit derived from INS-1, the rat insulin-secreting cell line.
58 -stimulated insulin secretion (GSIS) in both insulin-secreting cell lines (INS-1 and MIN6) and mouse
59     The effect was observed in two different insulin-secreting cell lines and in rat pancreatic islet
60                                              Insulin-secreting cell lines encapsulated in alginate-ba
61 tudies in our group are directed at creating insulin-secreting cell lines that simulate the performan
62 es have been studied using rodent islets and insulin-secreting cell lines, but very little is known a
63 sults from the autoimmune destruction of the insulin-secreting cells of the pancreas.
64                         The encapsulation of insulin-secreting cells offers a promising strategy for
65                                           In insulin-secreting cells, rescue of both mutant channels
66 tups aiming at developing glucose-responsive insulin-secreting cells, such as pluripotent stem-cell d
67 cts in human pancreatic beta-cells and INS-1 insulin-secreting cells to mobilize Ca(2+) from intracel
68 duce pancreatic beta-cells; the loss of this insulin-secreting cell type underlies type 1 diabetes.
69 + (KATP) channels was examined in rat CRI-G1 insulin-secreting cells using patch clamp and fluorescen
70  on mesenchyme give rise to glucose-sensing, insulin-secreting cells when transplanted in vivo.
71 the use of hydrogels in the encapsulation of insulin secreting cells with a special emphasis on hydro
72                                 Treatment of insulin-secreting cells with unloaded DIANAs did not imp
73 rboxyl methylation of CDC42 in five types of insulin-secreting cells, without blocking GTPgammaS-indu